RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Avadel Pharmaceuticals Market capitalization 2024

Avadel Pharmaceuticals Market capitalization

1.26 B USD

Avadel Pharmaceuticals Dividend yield

Ticker

AVDL

ISIN

US05337M1045

WKN

A2DJR8

In 2024, Avadel Pharmaceuticals's market cap stood at 1.26 B USD, a 6.04% increase from the 1.19 B USD market cap in the previous year.

The Avadel Pharmaceuticals Market capitalization history

YEARREVENUE (undefined USD)GROSS MARGIN (%)NET INCOME (undefined USD)
2029e563.14,82234.32
2028e509.815,32270.6
2027e465.015,83238.9
2026e389.76,96158.83
2025e297.749,1199.58
2024e165.4216,39-39.32
202327.9696,97-160.28
2022---137.5
2021---77.3
202022.374,447
201959.279,56-33.2
2018103.383,06-95.3
2017173.290,5968.3
2016150.291,21-41.3
201517393,4141.8
20141577,33-85.5
20134.285,71-42.9
20127.594,67-3.2
201132.680,67-8.8
201037.181,40-9
200942.176,01-11.4
200838.675,13-12.1
200736.752,59-37.7
20062373,04-35.2
200523.689,41-27.4
200455.493,5012.5

Avadel Pharmaceuticals Aktienanalyse

What does Avadel Pharmaceuticals do?

Avadel Pharmaceuticals PLC is an Irish pharmaceutical company that focuses on the development, manufacturing, and marketing of pharmaceutical products. The company was founded in 1999 under the name Flamel Technologies and was renamed Avadel Pharmaceuticals in 2019 to support its rebranding strategy and expand its activities in the global market. Avadel's business model is based on the discovery and development of therapies for rare diseases and sleep-related disorders, as well as the manufacturing and marketing of generic drugs and specialty products. The company is divided into three main segments: specialty pharmaceuticals, generic pharmaceuticals, and the Pediarix division. Avadel's specialty pharmaceuticals segment focuses on developing drugs for patients with rare diseases such as Prader-Willi syndrome or narcolepsy. An example of an innovative product in this segment is Rekarbri, an ORP medication for the treatment of narcolepsy. It is the first drug in the EU specifically tailored to the specific needs of narcolepsy patients and has improved patients' quality of life. The generic pharmaceuticals segment of Avadel offers high-quality and cost-effective medications that treat commonly prescribed and everyday conditions such as pain, infections, depression, and anxiety disorders. Most products in this segment are manufactured in the USA and are available in many countries worldwide. Avadel's Pediarix division specializes in the development and manufacturing of children's medicines. This includes products for the treatment of attention deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASD). An example of a product from this segment is Reagila, a medication for the treatment of ADHD in children that is known for its improved efficacy and lower risk of side effects. Avadel also has a geographically distributed business structure that allows it to market its products worldwide. The company has a strong presence in the USA and is represented in Europe, Asia, and Australia. It has an impressive research and development infrastructure, including manufacturing facilities and research facilities, that allow it to meet the needs of its customers. Overall, Avadel Pharmaceuticals is a leading pharmaceutical company that focuses on researching new and innovative therapies for patients with rare diseases and sleep-related disorders. The company has demonstrated its ability to bring effective products to the market while maintaining the highest standards in quality assurance and customer service. It is expected that Avadel will continue to grow in the future and introduce new and innovative products to help its customers and patients worldwide. Avadel Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Avadel Pharmaceuticals's Market Capitalization

Avadel Pharmaceuticals's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Avadel Pharmaceuticals's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Avadel Pharmaceuticals's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Avadel Pharmaceuticals’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Avadel Pharmaceuticals Stock

What is the current Avadel Pharmaceuticals market capitalization?

The current market capitalization of Avadel Pharmaceuticals is 1.26 B USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Avadel Pharmaceuticals.

How has the market capitalization of Avadel Pharmaceuticals developed in recent years?

The market capitalization of Avadel Pharmaceuticals has increased/decreased by 6.04% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Avadel Pharmaceuticals?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Avadel Pharmaceuticals?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Avadel Pharmaceuticals have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Avadel Pharmaceuticals pay?

Over the past 12 months, Avadel Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Avadel Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Avadel Pharmaceuticals?

The current dividend yield of Avadel Pharmaceuticals is .

When does Avadel Pharmaceuticals pay dividends?

Avadel Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Avadel Pharmaceuticals?

Avadel Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Avadel Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Avadel Pharmaceuticals located?

Avadel Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Avadel Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Avadel Pharmaceuticals from 5/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/21/2024.

When did Avadel Pharmaceuticals pay the last dividend?

The last dividend was paid out on 5/21/2024.

What was the dividend of Avadel Pharmaceuticals in the year 2023?

In the year 2023, Avadel Pharmaceuticals distributed 0 USD as dividends.

In which currency does Avadel Pharmaceuticals pay out the dividend?

The dividends of Avadel Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Avadel Pharmaceuticals

Our stock analysis for Avadel Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Avadel Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.